Shield Therapeutics plc (AIM:STX)
United Kingdom · Delayed Price · Currency is GBP · Price in GBX 5.75
+0.20 (3.60%)
Oct 21, 2026, 4:24 PM BST
Shield Therapeutics Market Cap
Shield Therapeutics has a market cap or net worth of 60.98 million as of October 21, 2026. It is the 26,662nd most valuable company in the world and the 589th biggest in the United Kingdom. Its market cap has decreased by 24.92% in one year.
Market Cap
60.98M
Enterprise Value
73.46M
Revenue
44.19M
Global Rank
Country Rank
#589 United Kingdom
PE Ratio
n/a
ChartMarket Cap Chart
Since February 26, 2016, Shield Therapeutics's market cap has decreased from 169.77M to 60.98M, a decrease of -64.08%. That is a compound annual growth rate of -9.16%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 21, 2026 | 60.98M | -41.69% |
| Dec 31, 2025 | 104.59M | 395.31% |
| Dec 31, 2024 | 21.12M | -59.70% |
| Dec 29, 2023 | 52.40M | 186.53% |
| Dec 30, 2022 | 18.29M | -80.96% |
| Dec 31, 2021 | 96.06M | 28.62% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Haleon | 33.04B |
| Hikma Pharmaceuticals | 3.47B |
| HUTCHMED (China) | 1.88B |
| Allergy Therapeutics | 284.96M |
| ECO Animal Health Group | 63.69M |
| Provexis | 19.94M |
| Hellenic Dynamics | 1.32M |
| Chill Brands Group | 915.12K |